Ceribell, Inc. (CBLL)
19.45
+0.20
(+1.04%)
USD |
NASDAQ |
Apr 30, 10:27
Ceribell EPS Diluted (Quarterly) : -0.3634 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.074 |
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -1.03 |
| Atossa Therapeutics, Inc. | -1.270 |
| Abeona Therapeutics, Inc. | -0.3717 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.53M |
| Revenue (Quarterly) | 24.78M |
| Total Expenses (Quarterly) | 38.31M |
| Enterprise Value | 587.61M |
| Gross Profit Margin (Quarterly) | 87.33% |
| Profit Margin (Quarterly) | -54.58% |
| Earnings Yield | -7.51% |
| Normalized Earnings Yield | -7.513 |